Dermira, inc. (DERM)
Income statement / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenue:
Collaboration revenue from a related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,300

-

-

-

-

-

-

-

-

-

-

Total revenue

11,533

66,645

2,452

2,243

717

39,080

299

1,343

1,066

1,066

1,066

-

119

-

-

-

-

-

-

7,300

-

-

-

-

-

-

-

Costs and operating expenses:
Cost of sales

1,932

1,335

926

-

237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

18,416

18,285

15,569

19,119

16,292

19,545

25,591

27,783

30,788

25,978

19,860

20,860

17,784

21,668

22,854

24,358

18,890

13,495

10,088

11,034

6,028

6,963

6,685

5,540

3,619

3,891

4,887

Acquired in-process research and development

-

-

-

-

-

-

-

-

128,555

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

46,356

63,327

48,679

51,791

49,510

40,770

30,510

27,236

19,754

13,587

11,326

9,493

8,276

6,373

5,901

5,043

4,684

3,848

4,146

3,048

1,688

1,740

1,812

1,152

1,009

971

1,234

Impairment of intangible assets

-

-

-

0

0

0

1,126

-

-

-

-

-

-

-

-

2,394

-

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

66,704

82,947

65,174

72,740

66,039

60,315

57,227

55,019

179,097

39,565

31,186

30,353

26,060

28,041

28,755

31,795

23,574

17,343

14,234

14,082

7,716

8,703

8,497

6,692

4,628

4,862

6,121

Loss from operations

-55,171

-16,302

-62,722

-70,497

-65,322

-21,235

-56,928

-53,676

-178,031

-38,499

-30,120

-7,887

-25,941

-28,041

-28,755

-31,795

-16,274

-17,343

-14,234

-6,782

-7,716

-8,703

-8,497

-6,692

-4,628

-4,862

-6,121

Interest and other income, net

1,948

1,970

1,551

1,918

2,198

2,037

1,734

1,620

1,721

1,253

611

504

431

286

319

178

259

222

237

125

-84

-25

-9

-13

-37

20

-8

Interest expense

4,398

3,630

3,661

3,231

3,420

4,734

4,254

-

2,864

1,320

-

-

-

-

-

32

39

38

38

39

47

34

33

9

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-124

-

-

-

-

-

-

-

-

-

-

-

Loss before taxes

-57,621

-17,962

-64,832

-71,810

-66,544

-23,932

-59,448

-56,012

-179,174

-38,566

-29,509

-

-

-

-28,436

-31,773

-16,054

-17,159

-14,035

-6,696

-7,847

-8,762

-8,539

-6,714

-4,665

-4,842

-6,129

Benefit for income taxes

-

-

-

0

0

0

-194

-

-

-

-

-

-

-

-

-622

-

-

-

31

-

-

-

-

-

-

-

Net loss

-57,621

-17,962

-64,832

-71,810

-66,544

-23,932

-59,254

-56,012

-179,174

-38,566

-29,509

-7,383

-25,510

-27,755

-28,436

-31,151

-16,054

-17,159

-14,035

-6,727

-7,847

-8,762

-8,539

-6,714

-4,665

-4,842

-6,129

Net loss per share, basic and diluted

-1.06

-0.33

-1.49

-1.70

-1.58

-0.57

-1.42

-1.46

-4.30

-0.93

-0.79

-0.14

-0.72

-0.89

-0.95

-1.04

-0.58

-0.69

-0.57

-0.29

-8.66

-9.72

-9.56

-7.56

-5.57

-6.09

-7.79

Weighted-average common shares used to compute net loss per share, basic and diluted

54,460

54,033

43,585

42,197

42,066

41,922

41,827

41,780

41,625

41,553

37,290

35,681

35,429

31,088

29,980

29,938

27,553

24,694

24,655

22,822

906

901

893

887

836

794

786

Product Sales
Total revenue

10,228

8,060

2,452

-

717

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and License Revenue
Total revenue

1,305

58,585

-

0

0

39,080

299

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-